Posts Tagged ‘contraception’
Founder Reflections on 2023
As I reflect on this past year, 2023 finally brought us some wins in reproductive health. And I personally had the opportunity to contribute to landmark steps forward. ⭐️ The FDA made long awaited changes to the mifepristone REMS program to allow pharmacies to dispense the essential medication. I was part of the research team…
Read MoreUpdated Report on State Policy Efforts to Expand Access to Contraception in Pharmacies
Download free 22-page report describing the current landscape of direct access to contraception in pharmacies, state policy approaches and experiences, as well as implementation.
Read MoreOutreach Initiative to Expand Access to Depot Medroxyprogesterone Acetate (DMPA)
New training program by Birth Control Pharmacist and Provide includes pharmacy best practices to combat stigma and communication guides and online resources to help connect patients with local resources.
Read MoreWebinar Introduces Pharmacists to New Hormonal Contraceptives
New training program by Birth Control Pharmacist and Provide includes pharmacy best practices to combat stigma and communication guides and online resources to help connect patients with local resources.
Read MoreWebinar Equips Pharmacists to Provide Contraception Care During COVID-19
New training program by Birth Control Pharmacist and Provide includes pharmacy best practices to combat stigma and communication guides and online resources to help connect patients with local resources.
Read MoreNew Webinar Prepares Pharmacists to Provide Reproductive Health Services and Referrals
New training program by Birth Control Pharmacist and Provide includes pharmacy best practices to combat stigma and communication guides and online resources to help connect patients with local resources.
Read MoreMeet Phexxi – A New Non-Hormonal Contraceptive Gel
About the Product Lactic acid, citric acid, and potassium bitartrate (Phexxi, Evofem Biosciences) is a prescription combination, non-hormonal contraceptive gel approved by the FDA in May 2020. The vaginal gel was found to be 86.3% effective with typical use when inserted up to 1 hour before vaginal intercourse.1 The gel acts as a contraceptive by…
Read MoreMeasuring Blood Pressure: An Important Prerequisite to Prescribing Hormonal Contraception
Why is it important to measure blood pressure before prescribing hormonal contraception? Combined hormonal contraceptives (CHCs) are a relatively safe and effective method for your patients in preventing pregnancy and treating other disease states such as menorrhagia, endometriosis, PCOS and more. However, CHCs may increase the risk for a few serious cardiovascular events. This risk…
Read MoreEffectiveness of Hormonal Contraceptives in Patients with Higher Weights
Introduction Obesity is becoming more prevalent every year and as pharmacists, it is important to revisit current contraceptive options for these patients. Overweight patients are defined as having a BMI ranging from >25-29.9 kg/m2 and obese patients a BMI >30 kg/m2. Currently there are no safety contraindications in patients with a BMI > 25 kg/m2…
Read MoreFinding Gluten-Free Oral Contraceptive Options for Your Patients
Patients with celiac disease or who otherwise follow a gluten-free diet need to be aware of potential sources of gluten, especially in medications such as oral contraceptives. The FDA defines gluten as “proteins that naturally occur in [wheat, barley, and rye or their crossbred hybrids] and that may cause adverse health effects in persons with…
Read More